Literature DB >> 8437027

The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. I. Natural history.

K M Bushby1, D Gardner-Medwin.   

Abstract

We have investigated 67 patients with proven Becker muscular dystrophy (BMD) using a standard protocol including a detailed history and a functional and clinical examination. Our aim was to define the natural history of the disease in a large cohort of patients in the light of the diagnostic methods now available. In all patients with or without an X-linked family history, the diagnosis was confirmed by the identification of a deletion or other abnormality in the dystrophin gene, and abnormal dystrophin on immunoblotting and immunocytochemistry of muscle biopsy samples. In graphs of functional and muscle score against age, two groups of patients emerged. In the larger group the disease was milder and patients remained ambulant into their forties or beyond. A smaller group had more severe disease with a slightly earlier onset, much earlier loss of ambulation, more frequent abnormal electrocardiographic findings and much lower reproductive fitness. The relationship of these clinical findings to the genetic and protein abnormalities found in the patients is explored in the accompanying paper.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8437027     DOI: 10.1007/bf00858725

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  25 in total

1.  Survival in x-chromosomal muscular dystrophy.

Authors:  F E DREIFUSS; G R HOGAN
Journal:  Neurology       Date:  1961-08       Impact factor: 9.910

2.  Reproductive fitness and frequency of new mutations in Becker muscular dystrophy: implications for genetic risk estimates.

Authors:  M R Passos-Bueno; M Zatz
Journal:  J Med Genet       Date:  1991-04       Impact factor: 6.318

Review 3.  Genetics of Duchenne muscular dystrophy.

Authors:  R G Worton; M W Thompson
Journal:  Annu Rev Genet       Date:  1988       Impact factor: 16.830

4.  Mild and severe forms of X-linked muscular dystrophy.

Authors:  R F Shaw; F E Dreifuss
Journal:  Arch Neurol       Date:  1969-05

5.  Benign sex-linked muscular dystrophy. Clinical and pathological features.

Authors:  O N Markand; R R North; A N D'Agostino; D D Daly
Journal:  Neurology       Date:  1969-07       Impact factor: 9.910

Review 6.  Clinical features and classification of the muscular dystrophies.

Authors:  D Gardner-Medwin
Journal:  Br Med Bull       Date:  1980-05       Impact factor: 4.291

7.  Prevalence and incidence of Becker muscular dystrophy.

Authors:  K M Bushby; M Thambyayah; D Gardner-Medwin
Journal:  Lancet       Date:  1991-04-27       Impact factor: 79.321

8.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

9.  The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. II. Correlation of phenotype with genetic and protein abnormalities.

Authors:  K M Bushby; D Gardner-Medwin; L V Nicholson; M A Johnson; I D Haggerty; N J Cleghorn; J B Harris; S S Bhattacharya
Journal:  J Neurol       Date:  1993-02       Impact factor: 4.849

10.  Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history.

Authors:  M H Brooke; G M Fenichel; R C Griggs; J R Mendell; R Moxley; J P Miller; M A Province
Journal:  Muscle Nerve       Date:  1983-02       Impact factor: 3.217

View more
  33 in total

1.  Two children with muscular dystrophies ascertained due to referral for diagnosis of autism.

Authors:  Lonnie Zwaigenbaum; Mark Tarnopolsky
Journal:  J Autism Dev Disord       Date:  2003-04

Review 2.  Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies.

Authors:  Elisabeth Le Rumeur
Journal:  Bosn J Basic Med Sci       Date:  2015-07-20       Impact factor: 3.363

3.  Clinical Utility Gene Card for: Becker muscular dystrophy.

Authors:  David Coote; Mark R Davis; Macarena Cabrera; Merrilee Needham; Nigel G Laing; Kristen J Nowak
Journal:  Eur J Hum Genet       Date:  2018-02-21       Impact factor: 4.246

4.  Quantitative Muscle MRI Protocol as Possible Biomarker in Becker Muscular Dystrophy.

Authors:  Lorenzo Maggi; Marco Moscatelli; Rita Frangiamore; Federica Mazzi; Mattia Verri; Alberto De Luca; Maria Barbara Pasanisi; Giovanni Baranello; Irene Tramacere; Luisa Chiapparini; Maria Grazia Bruzzone; Renato Mantegazza; Domenico Aquino
Journal:  Clin Neuroradiol       Date:  2020-01-23       Impact factor: 3.649

5.  Diagnostic Accuracy of Phenotype Classification in Duchenne and Becker Muscular Dystrophy Using Medical Record Data1.

Authors:  Jennifer G Andrews; Molly M Lamb; Kristin Conway; Natalie Street; Christina Westfield; Emma Ciafaloni; Dennis Matthews; Christopher Cunniff; Shree Pandya; Deborah J Fox
Journal:  J Neuromuscul Dis       Date:  2018

6.  How the magnitude of clinical severity and recurrence risk affects reproductive decisions in adult males with different forms of progressive muscular dystrophy.

Authors:  S Eggers; M Zatz
Journal:  J Med Genet       Date:  1998-03       Impact factor: 6.318

Review 7.  Cardiac involvement in Duchenne and Becker muscular dystrophy.

Authors:  Sophie Mavrogeni; George Markousis-Mavrogenis; Antigoni Papavasiliou; Genovefa Kolovou
Journal:  World J Cardiol       Date:  2015-07-26

8.  The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. II. Correlation of phenotype with genetic and protein abnormalities.

Authors:  K M Bushby; D Gardner-Medwin; L V Nicholson; M A Johnson; I D Haggerty; N J Cleghorn; J B Harris; S S Bhattacharya
Journal:  J Neurol       Date:  1993-02       Impact factor: 4.849

9.  Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2. Correlations within individual patients.

Authors:  L V Nicholson; M A Johnson; K M Bushby; D Gardner-Medwin; A Curtis; I B Ginjaar; J T den Dunnen; J L Welch; T J Butler; E Bakker
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

10.  Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups.

Authors:  L V Nicholson; M A Johnson; K M Bushby; D Gardner-Medwin; A Curtis; I B Ginjaar; J T den Dunnen; J L Welch; T J Butler; E Bakker
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.